Cardinal Health, Inc.

NYSE:CAH

Medical - Distribution

Healthcare
$278.32 -1.66%

-$3.77 today

Market cap
$64.33B
Beta
0.53
P/E (TTM)
33.5
EPS (TTM)
$6.63
Dividend yield
0.92%
52W Low $137.75High $233.60

Volume 1.35M

Average 2.11M

CAH Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Cardinal Health, Inc.NYSE: CAH

Accounts Payables · Q1 FY2027 · quarter ended Sep 2026

Accounts payables growth accelerates

Q1 FY2027 accounts payables of $2.65B rose 23.6% year over year, ahead of the -36.7% change in trailing-twelve-month accounts payables. Sequentially, it rose 489.6% from the prior quarter. Over 3 fiscal years it compounded at +7.1% a year.

Context

  • Accounts payables amounted to 1.4% of revenue in FY2026, up 0.1 pp from a year earlier.
  • Accounts payables increased in 2 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +23.6% holds above the trailing-twelve-month pace of -36.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$2.65B+489.6% QoQ
Last fiscal yearJun 2026
$3.46B+26.8% YoY
LTMSep 2026
$3.97B-36.7% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+23.6%——
1 year+26.8%——
3-year CAGR+7.1%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2026
3.46B USD
Year-over-year change
+26.8%
4-year CAGR
+0.3%

Accounts Payables vs competitors

How CAH compares with its peers on the latest reported figures

  • CAH's LTM Sep 2026 accounts payables of $3.97B is the 3rd largest of the 4 companies compared; the peer median is $4.39B.
  • Its year-over-year change of -36.7% is the lowest of 4, against a peer median of +453.0%.
  • Accounts payables amounts to 1.5% of revenue for CAH, versus a peer median of 1.5%.
CAH Competitors Peer median
Accounts Payables for CAH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MCKMcKesson CorporationLTM Jun 2026$6.14B +215.5%+4.5%1.5%
CORCencora, Inc.LTM Jun 2026$4.39B +453.0%+3.6%1.3%
CAHCardinal Health, Inc.LTM Sep 2026$3.97B -36.7%+7.1%1.5%
HSICHenry Schein, Inc.LTM Jun 2026$310M +785.7%—2.3%
Peer median (excluding CAH) $4.39B+453.0%+4.0%1.5%

Competitors are the stored peer set for CAH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Net Income(933M)331M853M1.57B1.71B
Depreciation & Amortization692M692M710M790M956M
Deferred Income Tax7M(40M)(104M)243M91M
Stock-Based Compensation096M121M244M367M
Change in Working Capital1.12B457M1.51B(523M)2.09B
Accounts Receivables(1.53B)(950M)(996M)(833M)(408M)
Inventory(1.07B)(412M)1.12B(1.82B)(488M)
Accounts Payables3.43B2.82B1.82B2.73B3.46B
Other Working Capital293M(997M)(433M)(606M)(481M)
Other Non-Cash Items2.23B1.31B672M74M(31M)
Operating Cash Flow3.12B2.84B3.76B2.4B5.17B
Capital Expenditures(387M)(481M)(511M)(547M)(649M)
Acquisitions (Net)901M(10M)(1.19B)(5.25B)(1.99B)
Purchases of Investments(78M)0(550M)00
Sales of Investments100M29M384M202M41M
Other Investing Activities31M8M18M(10M)15M
Investing Cash Flow567M(454M)(1.85B)(5.61B)(2.58B)
Debt Repayment(885M)(579M)356M3.22B337M
Common Stock Issued00000
Common Stock Repurchased(1B)(2B)(750M)(765M)(1.36B)
Dividends Paid(559M)(525M)(499M)(494M)(491M)
Other Financing Activities(19M)53M46M(13M)(90M)
Financing Cash Flow(2.46B)(3.05B)(847M)1.95B(1.6B)
Effect of Forex Changes84M(8M)(9M)(3M)(6M)
Net Change in Cash1.31B(669M)1.06B(1.26B)982M
Free Cash Flow2.74B2.36B3.25B1.85B4.53B

Cardinal Health, Inc.

NYSE:CAH

Intrinsic Alpha fair value

Locked

Current Price

$278.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.